Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study

CONCLUSIONS: In patients with stable CAD treated with pitavastatin and who achieved guidelines-directed levels of LDL-C, eGFR and HbA1c were independently associated with adverse events, suggesting that renal function and glycemic control could be residual non-lipid therapeutic targets after statin therapy.PMID:37574272 | DOI:10.5551/jat.64304

Source: Journal of Atherosclerosis and Thrombosis - August 13, 2023 Category: Cardiology Authors: Kiwamu Kamiya Makoto Takei Toshiyuki Nagai Toru Miyoshi Hiroshi Ito Yoshihiro Fukumoto Hitoshi Obara Tatsuyuki Kakuma Ichiro Sakuma Hiroyuki Daida Satoshi Iimuro Hiroaki Shimokawa Takeshi Kimura Ryozo Nagai Toshihisa Anzai REAL-CAD study investigators Source Type: research